Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The SCALE trial measured outcomes at week 56, showing the 8% average body weight reduction
Currently have or have a history of diabetic retinopathy
The program follows a structured roadmap that adapts to your needs: Months 13 : Focus on learning how to use the injection pen and setting both short-term and long-term health goals
Microdosing Semaglutide: A closer look Semaglutide is a GLP-1 receptor agonist that mimics the hormone your body releases after eating
Per the brand's own framing: People who want to support gut health as part of a broader wellness routine Anyone who'd rather try an over-the-counter option before considering prescription medication Anyone who doesn't have access to or doesn't qualify for prescription GLP-1 drugs Anyone who specifically wants a stimulant-free approach Who might it not fit
US$ 25.95
US$ 21.66
US$ 24.63
US$ 28.51
